Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.
This study has been withdrawn prior to enrollment.
First Posted: December 15, 2010
Last Update Posted: October 21, 2011
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||No date given|
|Primary Completion Date:||No date given|